Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity

Microarray expression profiles reveal substantial changes in gene expression in the ipsilateral dorsal horn of the spinal cord in response to three peripheral nerve injury models of neuropathic pain. However, only 54 of the 612 regulated genes are commonly expressed across all the neuropathic pain models. Many of the commonly regulated transcripts are immune related and include the complement components C1q, C3, and C4, which we find are expressed only by microglia. C1q and C4 are, moreover, the most strongly regulated of all 612 regulated genes. In addition, we find that the terminal complement component C5 and the C5a receptor (C5aR) are upregulated in spinal microglia after peripheral nerve injury. Mice null for C5 had reduced neuropathic pain sensitivity, excluding C3a as a pain effector. C6-deficient rats, which cannot form the membrane attack complex, have a normal neuropathic pain phenotype. However, C5a applied intrathecally produces a dose-dependent, slow-onset cold pain in naive animals. Furthermore, a C5aR peptide antagonist reduces cold allodynia in neuropathic pain models. We conclude that induction of the complement cascade in spinal cord microglia after peripheral nerve injury contributes to neuropathic pain through the release and action of the C5a anaphylatoxin peptide.

[1]  J. A. Hartigan,et al.  A k-means clustering algorithm , 1979 .

[2]  Y. Imai,et al.  A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. , 1996, Biochemical and biophysical research communications.

[3]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[4]  S. McMahon,et al.  Role of the Immune system in chronic pain , 2005, Nature Reviews Neuroscience.

[5]  P. Feldhoff,et al.  Recombinant rat IL-1beta and IL-6 synergistically enhance C3 mRNA levels and complement component C3 secretion by H-35 rat hepatoma cells. , 2005, Cytokine.

[6]  P. Ward,et al.  Role of C5a in inflammatory responses. , 2005, Annual review of immunology.

[7]  S. Maier,et al.  Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions , 2004, The European journal of neuroscience.

[8]  Lan Bao,et al.  Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Todd,et al.  Do central terminals of intact myelinated primary afferents sprout into the superficial dorsal horn of rat spinal cord after injury to a neighboring peripheral nerve? , 2004, The Journal of comparative neurology.

[10]  Andreas Persidis,et al.  Novel biological networks modulated by complement. , 2005, Clinical immunology.

[11]  O. Hommes,et al.  Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system , 2000, Acta neurologica Scandinavica.

[12]  J. Deleo,et al.  Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: potential role of IL-6 in neuropathic pain. , 1998, Brain research. Molecular brain research.

[13]  J. Lambris,et al.  C3a Is Required for the Production of CXC Chemokines by Tubular Epithelial Cells after Renal Ishemia/Reperfusion1 , 2007, The Journal of Immunology.

[14]  V. Tawfik,et al.  Differential Spinal Cord Gene Expression in Rodent Models of Radicular and Neuropathic Pain , 2006, Anesthesiology.

[15]  J. Deleo,et al.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[17]  C. Woolf,et al.  Can we conquer pain? , 2002, Nature Neuroscience.

[18]  B. Winkelstein,et al.  Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment , 2001, The Journal of comparative neurology.

[19]  M. Tsuda,et al.  Neuropathic pain and spinal microglia: a big problem from molecules in ‘small’ glia , 2005, Trends in Neurosciences.

[20]  Complement C5a Receptor-Mediated Signaling May Be Involved in Neurodegeneration in Alzheimer’s Disease1 , 2003, The Journal of Immunology.

[21]  J. Mudgett,et al.  Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Gravel,et al.  BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain , 2005, Nature.

[23]  H. Perez,et al.  Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg. , 1985, Journal of immunology.

[24]  Jörn Lötsch,et al.  GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence , 2006, Nature Medicine.

[25]  P. Gasque,et al.  Activation of Complement in the Central Nervous System , 2003, Annals of the New York Academy of Sciences.

[26]  John (Sam) Keltner,et al.  Facilitation , 1989, Abécédaire de la philosophie pour enfants.

[27]  S. Snyder,et al.  Parapinopsin, a Novel Catfish Opsin Localized to the Parapineal Organ, Defines a New Gene Family , 1997, The Journal of Neuroscience.

[28]  G. Gebhart,et al.  Descending modulation of pain , 2004, Neuroscience & Biobehavioral Reviews.

[29]  D. Gerhold,et al.  Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases , 2002, Neuroscience.

[30]  J. Deleo,et al.  Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. , 2001, The Journal of pharmacology and experimental therapeutics.

[31]  T. Speed,et al.  Analysis of gene expression in the developing mouse retina , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Woolf,et al.  Neuronal plasticity: increasing the gain in pain. , 2000, Science.

[33]  J. Laufer,et al.  Extrahepatic synthesis of complement proteins in inflammation. , 2001, Molecular immunology.

[34]  R. Yezierski,et al.  The role of neuroinflammation and neuroimmune activation in persistent pain , 2001, Pain.

[35]  C. Woolf,et al.  Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.

[36]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[37]  S. Maier,et al.  Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation , 2005, Pain.

[38]  C. Woolf,et al.  Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC‐dependent site, serine‐896, in spinal cord dorsal horn neurons , 2004, The European journal of neuroscience.

[39]  R. Evans,et al.  Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling , 2022 .

[40]  S. Waxman.  Transcriptional channelopathies: An emerging class of disorders , 2001, Nature Reviews Neuroscience.

[41]  C. Woolf,et al.  p38 Mitogen-Activated Protein Kinase Is Activated after a Spinal Nerve Ligation in Spinal Cord Microglia and Dorsal Root Ganglion Neurons and Contributes to the Generation of Neuropathic Pain , 2003, The Journal of Neuroscience.

[42]  J. Deleo,et al.  Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain , 2004, Neurochemistry International.

[43]  J. Weinstein,et al.  Spinal glial activation and cytokine expression after lumbar root injury in the rat. , 2000, Spine.

[44]  M. Frank.  Animal models for complement deficiencies , 1995, Journal of Clinical Immunology.

[45]  Yves De Koninck,et al.  Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain , 2003, Nature.

[46]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[47]  S. Barnum,et al.  Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats. , 1997, Brain research. Molecular brain research.

[48]  R. Coggeshall,et al.  Blocking Caspase Activity Prevents Transsynaptic Neuronal Apoptosis and the Loss of Inhibition in Lamina II of the Dorsal Horn after Peripheral Nerve Injury , 2005, The Journal of Neuroscience.

[49]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.

[50]  Mario Saltarelli,et al.  Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. , 2003, Archives of neurology.

[51]  M. Svensson,et al.  Glial cell responses, complement, and clusterin in the central nervous system following dorsal root transection , 1998, Glia.

[52]  Wiklund Ra,et al.  First of two parts , 1997 .

[53]  V. Tawfik,et al.  Neuroimmune Activation and Neuroinflammation in Chronic Pain and Opioid Tolerance/Hyperalgesia , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[54]  G. Church,et al.  Systematic determination of genetic network architecture , 1999, Nature Genetics.

[55]  Michael Costigan,et al.  Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. , 2002, BMC Neuroscience.

[56]  J. Deleo,et al.  Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines , 2003, Pain.

[57]  D. Craik,et al.  Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. , 1999, Journal of medicinal chemistry.

[58]  C. Woolf,et al.  Spared nerve injury: an animal model of persistent peripheral neuropathic pain , 2000, Pain.

[59]  J. Ochoa,et al.  Quantitative somatosensory thermotest. A key method for functional evaluation of small calibre afferent channels. , 1992, Brain : a journal of neurology.

[60]  M. Carroll,et al.  The complement system in regulation of adaptive immunity , 2004, Nature Immunology.

[61]  V. Tawfik,et al.  Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury , 2007, Brain, Behavior, and Immunity.

[62]  M. Angst,et al.  Blockade of the Complement C5a Receptor Reduces Incisional Allodynia, Edema, and Cytokine Expression , 2006, Anesthesiology.

[63]  P. J. Elliot,et al.  Changes in neuronal markers in a mononeuropathic rat model: relationship between neuropeptide Y, pre-emptive drug treatment and long-term mechanical hyperalgesia , 1995, Pain.

[64]  L. Sorkin,et al.  Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38 , 2005, Neuroscience Letters.

[65]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[66]  R. Veerhuis,et al.  Cytokines Associated with Amyloid Plaques in Alzheimer's Disease Brain Stimulate Human Glial and Neuronal Cell Cultures to Secrete Early Complement Proteins, But Not C1-Inhibitor , 1999, Experimental Neurology.

[67]  T. Barrette,et al.  C5a-induced gene expression in human umbilical vein endothelial cells. , 2004, The American journal of pathology.

[68]  Steven F. Maier,et al.  Glial activation: a driving force for pathological pain , 2001, Trends in Neurosciences.

[69]  R T Verrillo,et al.  Sensory functions in chronic neuralgia. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[70]  M. Shin,et al.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[71]  P. Gasque,et al.  "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. , 2003, Molecular immunology.

[72]  S. Maier,et al.  Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization. , 2005, The journal of pain : official journal of the American Pain Society.

[73]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[74]  Ali S. Hadi,et al.  Finding Groups in Data: An Introduction to Chster Analysis , 1991 .

[75]  Martin J. Stoermer,et al.  Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity. , 2004, Molecular pharmacology.